SHENZHEN, China, Oct. 22, 2026 /PRNewswire/ -- ELEGOO, a rapidly developing brand in global smart manufacturing, is expanding its 3D creation ecosystem with the upcoming M1 Ultra, its first all-in-one smart 3D scanner. Officially launching on October 29, 2026, at 12:00 AM PDT, the M1 Ultra marks a new addition to ELEGOO's product portfolio, extending its ecosystem into 3D scanning and enabling creators, engineers, and advanced hobbyists to capture real-world objects as accurate digital 3D data for a wide range of creative and practical applications.
By entering the 3D scanning category, ELEGOO aims to provide a more integrated workflow connecting real-world object capture, digital modeling, and 3D printing, opening up new possibilities for customization, reverse engineering, digital archiving, education, and creative projects.
Designed to deliver precision, versatility, and ease of use without compromise, M1 Ultra combines metrology-grade accuracy, multiple scanning modes, intelligent processing, and a portable all-in-one design. Its combination of blue laser and infrared structured-light scanning supports different objects and use cases, while marker-free scanning provides added flexibility for surfaces where applying tracking markers is not practical.
Beyond scanning performance, M1 Ultra is designed to make the overall process more efficient and flexible. An integrated touchscreen provides real-time previews and convenient access to settings, while wireless connectivity and a swappable battery offer greater freedom when scanning. On the software side, ELEGOO SCAN incorporates guided setup, tracking assistance, and automated data processing to help users move from capturing an object to generating a digital 3D model with fewer manual steps.
With M1 Ultra, ELEGOO is taking another step toward a more connected 3D creation ecosystem—one that helps users move more seamlessly between the physical and digital worlds, whether they are developing a custom part, exploring a design idea, or preparing an object for further digital work and 3D printing.
ELEGOO will give the M1 Ultra its first European debut at two upcoming events: Maker Faire Rome 2026 (October 23–25, booth M.21–M.22) and SPIEL Essen 2026 (October 22–25, booth H5L125). Visitors will get an exclusive first look at the scanner ahead of its official launch on October 29.
Pricing and additional key features will be unveiled on October 29, 2026. Stay tuned for more updates on ELEGOO's official website.
About ELEGOO
Founded in 2015, ELEGOO is a rapidly developing brand in the global smart manufacturing industry, specializing in R&D, manufacturing, and sales of consumer-grade 3D printers, laser engravers, STEM kits, and other smart technology products. Located in Shenzhen, the Silicon Valley of China, the company has sold millions of products across more than 150 countries and regions. In 2025, the company's total sales revenue surpassed 300 million USD, with more than 1000 employees and over 430,000 square meters of office and manufacturing area. With a focus on programming and 3D printing technology, ELEGOO provides unique and smart creation spaces for diverse consumers to enhance personalized experiences.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
ELEGOO Brings Professional-Grade 3D Scanning to a Wider Range of Creators with the Upcoming M1 Ultra
YICHANG, China, Oct. 23, 2026 /PRNewswire/ -- Angel Yeast (SSE: 600298), one of the world's leading yeast manufacturers, has hosted the 2026 International Synthetic Biology Symposium and the Angel Group High-Quality Development Conference in Yichang, its headquarters city, on October 19–20, 2026, as part of the company's 40th anniversary celebrations.
As a highlight of Angel Yeast's 40th anniversary, the event convened over 500 global industry partners, including academicians, experts, scholars, supplier representatives, and customer delegates from China and abroad. It offered a platform to discuss biomanufacturing and synthetic biology trends, industrial innovation, and global supply chain collaboration, showcasing Angel Yeast's strategy of deepening international cooperation through innovation, openness, and localized operations.
The event was both a celebration of Angel Yeast's journey and a launchpad for global partners to deepen biomanufacturing collaboration and shape future growth together.
At the High-Quality Development Conference, Angel Yeast reflected on its journey from starting as an edible yeast pilot base to becoming the world's second-largest producer by sales volume. Today, its products reach 170+ countries and regions, serving 30,000+ customers worldwide with over 20% market share.
In innovation, Angel Yeast has built an industrial microbial strain bank and mastered key technologies in strain selection, cell factory construction and multi-carbon source fermentation. The company invests over USD 149.8 million in R&D annually, employs more than 1,500 researchers, and collaborates with over 70 research institutes worldwide.
Angel Yeast has cumulatively obtained 534 authorized invention patents, with 12 scientific and technological achievements reaching international leading levels. The company has continuously optimized its market layout and refined a research-and-sales synergy mechanism adapted to its new development stage composing of 4 business segments, 6 overseas business divisions and 8 technology centers.
Globally, Angel Yeast operates a multi-regional production and R&D network. Its Egypt plant, after two expansions, is now the world's largest yeast factory, while its new Indonesia plant is set to begin production in Q1 next year. Overseas factories and subsidiaries employ nearly 2,000 foreign staff, with a localization rate exceeding 95%.
Angel Yeast is committed to a circular economy industrial chain: raw materials sourced from agricultural processing, core products serving food health and safety, and by-products feeding back into agriculture. It has built five National Green Factories and one zero-carbon factory, with its Ecovadis rating in the global top 15%. The company also participates in setting international standards, including the Codex Alimentarius standard for yeast products, driving the coordinated global expansion of its products, technologies, standards, and brand.
"Looking ahead, Angel Yeast will vigorously develop new synthetic biology technologies, focusing on new tracks such as future foods, biomedicine, enzyme catalysis and new materials, and agricultural microbiology. We will build a 'biomanufacturing+' industrial cluster, continuously propel the industrial chain toward the high end of the value chain, and strive to build a world-class biotechnology company," remarked Xiong Tao, Chairman of Angel Yeast.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Angel Yeast Marks 40th Anniversary, Setting Its Sights on Becoming a Global Biotech Powerhouse
